Psychedelic compounds have historically been categorized as 'psychotomimetics,' or substances that mimic symptoms of psychosis or schizophrenia. However, psychedelics have been implicated in treatments for mental health disorders, while psychosis is itself a severe mental disorder. How to explain this paradox? Haley Dourron, a PhD student at the University of Alabama at Birmingham, and Camilla Strauss '23 will discuss their upcoming paper on this phenomenon, delving into the similarities and differences between psychotic and psychedelic states and their behavioral outcomes. Hosted by the Princeton Science of Psychedelics Club.